Small animals models for drug discovery

Schuessler, 1995, A computer-controlled research ventilator for small animals: design and evaluation, IEEE Trans Biomed Eng, 42, 860, 10.1109/10.412653 1986, Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, Am Rev Respir Dis, 1987, 225 Shampain, 1982, An animal model of late pulmonary responses to alternaria challenge, Am Rev Respir Dis, 126, 493 Eidelman, 1988, Late airway responses to antigen challenge in sensitized inbred rats, Am Rev Respir Dis, 137, 1033, 10.1164/ajrccm/137.5.1033 Hamel, 1986, Late pulmonary responses induced by ascaris allergen in conscious squirrel monkeys, J Appl Physiol, 61, 2081, 10.1152/jappl.1986.61.6.2081 Soler, 1991, Separation of late bronchial responses from airway hyperresponsiveness in allergic sheep, J Appl Physiol, 70, 617, 10.1152/jappl.1991.70.2.617 Fornhem, 1995, Allergen-induced late-phase airways obstruction in the pig - the role of endogenous cortisol, Eur Respir J, 8, 928, 10.1183/09031936.95.08071100 Gauvreau, 2008, Antisense therapy against CCR3 and the common beta chain attenuates allergen-induced eosinophilic responses, Am J Respir Crit Care Med, 177, 952, 10.1164/rccm.200708-1251OC Wenzel, 2007, Effect of an interleukin-4 variant on late phase asthmatic response to allergen challenge in asthmatic patients: results of two phase 2a studies, Lancet, 370, 1422, 10.1016/S0140-6736(07)61600-6 Herszberg, 2006, Heaves, an asthma-like equine disease, involves airway smooth muscle remodeling, J Allergy Clin Immunol, 118, 382, 10.1016/j.jaci.2006.03.044 Hirt, 2009, Airway hyperresponsiveness to adenosine 5’-monophosphate in feline chronic inflammatory lower airway disease, Vet J Bartlett, 2008, Mouse models of rhinovirus-induced disease and exacerbation of allergic airway inflammation, Nat Med, 14, 199, 10.1038/nm1713 Hoymann, 2007, Invasive and noninvasive lung function measurements in rodents, J Pharmacol Toxicol Methods, 55, 16, 10.1016/j.vascn.2006.04.006 Bates, 2009, Pulmonary mechanics: a system identification perspective, Conf Proc IEEE Eng Med Biol Soc, 1, 170 Lundblad, 2007, Penh is not a measure of airway resistance!, Eur Respir J, 30, 805, 10.1183/09031936.00091307 Glaab, 2001, Tidal midexpiratory flow as a measure of airway hyperresponsiveness in allergic mice, Am J Physiol Lung Cell Mol Physiol, 280, L565, 10.1152/ajplung.2001.280.3.L565 Glaab, 2004, Repetitive measurements of pulmonary mechanics to inhaled cholinergic challenge in spontaneously breathing mice, J Appl Physiol, 97, 1104, 10.1152/japplphysiol.01182.2003 Thamrin, 2004, Sensitivity analysis of respiratory parameter estimates in the constant-phase model, Ann Biomed Eng, 32, 815, 10.1023/B:ABME.0000030257.88945.81 Kumar, 2002, Modeling allergic asthma in mice: pitfalls and opportunities, Am J Respir Cell Mol Biol, 27, 267, 10.1165/rcmb.F248 Mosmann, 1986, Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins, J Immunol, 136, 2348, 10.4049/jimmunol.136.7.2348 Harrington, 2005, Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages, Nat Immunol, 6, 1123, 10.1038/ni1254 Wolk, 2010, Biology of interleukin-22, Semin Immunopathol, 32, 17, 10.1007/s00281-009-0188-x Annunziato, 2009, Heterogeneity of human effector CD4+ T cells, Arthritis Res Ther, 11, 257, 10.1186/ar2843 Berlin, 2006, Inhibition of SCF attenuates peribronchial remodeling in chronic cockroach allergen-induced asthma, Lab Invest, 86, 557, 10.1038/labinvest.3700419 Nemeth, 2010, Bone marrow stromal cells use TGF-beta to suppress allergic responses in a mouse model of ragweed-induced asthma, Proc Natl Acad Sci U S A, 107, 5652, 10.1073/pnas.0910720107 Hammad, 2009, House dust mite allergen induces asthma via Toll-like receptor 4 triggering of airway structural cells, Nat Med, 15, 410, 10.1038/nm.1946 Lambrecht, 2009, Biology of lung dendritic cells at the origin of asthma, Immun, 31, 412, 10.1016/j.immuni.2009.08.008 Henrickson, 2008, T cell sensing of antigen dose governs interactive behavior with dendritic cells and sets a threshold for T cell activation, Nat Immunol, 9, 282, 10.1038/ni1559 Blink, 2010, IgE regulates T helper cell differentiation through FcgammaRIII mediated dendritic cell cytokine modulation, Cell Immunol, 264, 54, 10.1016/j.cellimm.2010.04.011 Ito, 2005, TSLP-activated dendritic cells induce an inflammatory T helper type 2 cell response through OX40 ligand, J Exp Med, 202, 1213, 10.1084/jem.20051135 Sokol, 2008, A mechanism for the initiation of allergen-induced T helper type 2 responses, Nat Immunol, 9, 310, 10.1038/ni1558 Yang, 2008, Eosinophil-derived neurotoxin acts as an alarmin to activate the TLR2-MyD88 signal pathway in dendritic cells and enhances Th2 immune responses, J Exp Med, 205, 79, 10.1084/jem.20062027 Dillon, 2004, A toll-like receptor 2 ligand stimulates Th2 responses in vivo, via induction of extracellular signal-regulated kinase mitogen-activated protein kinase and c-Fos in dendritic cells, J Immunol, 172, 4733, 10.4049/jimmunol.172.8.4733 Machida, 2004, Cysteinyl leukotrienes regulate dendritic cell functions in a murine model of asthma, J Immunol, 172, 1833, 10.4049/jimmunol.172.3.1833 Barrett, 2009, Dectin-2 recognition of house dust mite triggers cysteinyl leukotriene generation by dendritic cells, J Immunol, 182, 1119, 10.4049/jimmunol.182.2.1119 Huh, 2003, Bidirectional interactions between antigen-bearing respiratory tract dendritic cells (DCs) and T cells precede the late phase reaction in experimental asthma: DC activation occurs in the airway mucosa but not in the lung parenchyma, J Exp Med, 198, 19, 10.1084/jem.20021328 Watanabe, 1995, Transfer of allergic airway responses with antigen-primed CD4+ but not CD8+ T cells in brown Norway rats, J Clin Invest, 96, 1303, 10.1172/JCI118165 Sapienza, 1990, Role of leukotriene D4 in the early and late pulmonary responses of rats to allergen challenge, Am Rev Respir Dis, 142, 353, 10.1164/ajrccm/142.2.353 Martin, 1993, Leukotrienes in bile during the early and the late airway responses after allergen challenge of sensitized rats, Am Rev Respir Dis, 147, 104, 10.1164/ajrccm/147.1.104 Yu, 1995, Cellular infiltration and eicosanoid synthesis in brown Norway rat lungs after allergen challenge, Am J Respir Cell Mol Biol, 13, 477, 10.1165/ajrcmb.13.4.7546778 Cartier, 1982, Allergen-induced increase in bronchial responsiveness to histamine: relationship to the late asthmatic response and change in airway caliber, J Allergy Clin Immunol, 70, 170, 10.1016/0091-6749(82)90038-0 Yager, 1989, Amplification of airway constriction due to liquid filling of airway interstices, J Appl Physiol, 66, 2873, 10.1152/jappl.1989.66.6.2873 Wagers, 2004, The allergic mouse model of asthma: normal smooth muscle in an abnormal lung?, J Appl Physiol, 96, 2019, 10.1152/japplphysiol.00924.2003 Wagers, 2007, Intrinsic and antigen-induced airway hyperresponsiveness are the result of diverse physiological mechanisms, J Appl Physiol, 102, 221, 10.1152/japplphysiol.01385.2005 Dunnill, 1969, A comparison of the quantitative anatomy of the bronchi in normal subjects, in status asthmaticus, in chronic bronchitis and in emphysema, Thorax, 24, 176, 10.1136/thx.24.2.176 Heard, 1973, Hyperplasia of bronchial muscle in asthma, J Pathol, 110, 319, 10.1002/path.1711100406 Sapienza, 1991, Structural changes in the airways of sensitized Brown Norway rats after antigen challenge, Am Rev Respir Dis, 144, 423, 10.1164/ajrccm/144.2.423 Panettieri, 1995, Repeated allergen inhalations induce DNA synthesis in airway smooth muscle and epithelial cells in vivo, Chest, 107, S 94, 10.1378/chest.107.3_Supplement.94S Salmon, 1999, Repeated allergen exposure of sensitized Brown-Norway rats induces airway cell DNA synthesis and remodelling, Eur Respir J, 14, 633, 10.1034/j.1399-3003.1999.14c25.x Leigh, 2002, Dysfunction and remodeling of the mouse airway persist after resolution of acute allergen-induced airway inflammation, Am J Respir Cell Mol Biol, 27, 526, 10.1165/rcmb.2002-0048OC Henderson, 2002, A role for cysteinyl leukotrienes in airway remodeling in a mouse asthma model, Am J Respir Crit Care Med, 165, 108, 10.1164/ajrccm.165.1.2105051 Tamaoka, 2008, The epidermal growth factor receptor mediates allergic airway remodeling in the rat, Eur Respir J, 10.1183/09031936.00166907 Palmans, 2000, Prolonged allergen exposure induces structural airway changes in sensitized rats, Am J Respir Crit Care Med, 161, 627, 10.1164/ajrccm.161.2.9902094 Pini, 2006, Airway remodeling in allergen-challenged Brown Norway rats: distribution of proteoglycans, Am J Physiol Lung Cell Mol Physiol, 290, L1052, 10.1152/ajplung.00122.2005 Labonte, 2009, The effects of repeated allergen challenge on airway smooth muscle structural and molecular remodeling in a rat model of allergic asthma, Am J Physiol Lung Cell Mol Physiol, 297, L698, 10.1152/ajplung.00142.2009 Vanacker, 2001, Fluticasone inhibits but does not reverse allergen-induced structural airway changes, Am J Respir Crit Care Med, 163, 674, 10.1164/ajrccm.163.3.2004160 Kumar, 2002, Role of interleukin-13 in eosinophil accumulation and airway remodelling in a mouse model of chronic asthma, Clin Exp Allergy, 32, 1104, 10.1046/j.1365-2222.2002.01420.x Leigh, 2004, Type 2 cytokines in the pathogenesis of sustained airway dysfunction and airway remodeling in mice, Am J Respir Crit Care Med, 169, 860, 10.1164/rccm.200305-706OC Hogaboam, 2000, Chronic airway hyperreactivity, goblet cell hyperplasia, and peribronchial fibrosis during allergic airway disease induced by Aspergillus fumigatus, Am J Pathol, 156, 723, 10.1016/S0002-9440(10)64775-X Dharajiya, 2007, Pollen NAD(P)H oxidases and their contribution to allergic inflammation, Immunol Allergy Clin North Am, 27, 45, 10.1016/j.iac.2006.11.007 Tang, 2010, The T helper type 2 response to cysteine proteases requires dendritic cell-basophil cooperation via ROS-mediated signaling, Nat Immunol, 11, 608, 10.1038/ni.1883 Brooks, 1985, Reactive airways dysfunction syndrome (RADS). Persistent asthma syndrome after high level irritant exposures, Chest, 88, 376, 10.1378/chest.88.3.376 Andersson, 2006, Incidence of asthma among workers exposed to sulphur dioxide and other irritant gases, Eur Respir J, 27, 720, 10.1183/09031936.06.00034305 Takeda, 2009, Long-term pathologic consequences of acute irritant-induced asthma, J Allergy Clin Immunol, 124, 975, 10.1016/j.jaci.2009.08.008 McGovern, 2010, Dimethylthiourea protects against chlorine induced changes in airway function in a murine model of irritant induced asthma, Respir Res, 11, 138, 10.1186/1465-9921-11-138 Pichavant, 2008, Ozone exposure in a mouse model induces airway hyperreactivity that requires the presence of natural killer T cells and IL-17, J Exp Med, 205, 385, 10.1084/jem.20071507 Akbari, 2008, ICOS/ICOSL interaction is required for CD4+ invariant NKT cell function and Homeostatic survival, J Immunol, 180, 5448, 10.4049/jimmunol.180.8.5448 Jin, 2007, Airway hyperresponsiveness through synergy of gammadelta} T cells and NKT cells, J Immunol, 179, 2961, 10.4049/jimmunol.179.5.2961 Gavett, 1994, Depletion of murine CD4+ T lymphocytes prevents antigen-induced airway hyperreactivity and pulmonary eosinophilia, Am J Respir Cell Mol Biol, 10, 587, 10.1165/ajrcmb.10.6.8003337 Haczku, 1997, Adoptive transfer of allergen-specific CD4+ T cells induces airway inflammation and hyperresponsiveness in brown-Norway rats, Immunology, 91, 176, 10.1046/j.1365-2567.1997.d01-2221.x Isogai, 2004, CD8(+) alpha beta T cells can mediate late airway responses and airway eosinophilia in rats, J Allergy Clin Immunol, 114, 1345, 10.1016/j.jaci.2004.09.021 Isogai, 2007, Interferon-gamma-dependent inhibition of late allergic airway responses and eosinophilia by CD8+ gammadelta T cells, Immunology, 122, 230, 10.1111/j.1365-2567.2007.02632.x Joetham, 2007, Naturally occurring lung CD4(+)CD25(+) T cell regulation of airway allergic responses depends on IL-10 induction of TGF-beta, J Immunol, 178, 1433, 10.4049/jimmunol.178.3.1433 Curotto de Lafaille, 2008, Adaptive Foxp3+ regulatory T cell-dependent and -independent control of allergic inflammation, Immunity, 29, 114, 10.1016/j.immuni.2008.05.010 Wallace, 1997, Nonspecific airway hyperresponsiveness in HIV disease. Pulmonary complications of HIV infection study Group, Chest, 111, 121, 10.1378/chest.111.1.121 Alexander, 1992, Trial of cyclosporin in corticosteroid-dependent chronic severe asthma, Lancet, 339, 324, 10.1016/0140-6736(92)91646-P Xu, 2001, Inhaled budesonide inhibits OVA-induced airway narrowing, inflammation, and cys-LT synthesis in BN rats, J Appl Physiol, 89, 1852, 10.1152/jappl.2000.89.5.1852 Eum, 2003, Inhibition of allergic airways inflammation and airway hyperresponsiveness in mice by dexamethasone: role of eosinophils, IL-5, eotaxin, and IL-13, J Allergy Clin Immunol, 111, 1049, 10.1067/mai.2003.1416 Cox, 2007, Asthma control during the year after bronchial thermoplasty, N Engl J Med, 356, 1327, 10.1056/NEJMoa064707 Inman, 2001, Dose-dependent effects of inhaled mometasone furoate on airway function and inflammation after allergen inhalation challenge, Am J Respir Crit Care Med, 164, 569, 10.1164/ajrccm.164.4.2007063 Leung, 2005, Effects of ciclesonide and fluticasone propionate on allergen-induced airway inflammation and remodeling features, J Allergy Clin Immunol, 115, 989, 10.1016/j.jaci.2005.01.036 McKinley, 2008, TH17 cells mediate steroid-resistant airway inflammation and airway hyperresponsiveness in mice, J Immunol, 181, 4089, 10.4049/jimmunol.181.6.4089 Wilson, 2009, Allergic sensitization through the airway primes Th17-dependent neutrophilia and airway hyperresponsiveness, Am J Respir Crit Care Med, 180, 720, 10.1164/rccm.200904-0573OC Rabb, 1994, The role of the leukocyte adhesion molecules VLA-4, LFA-1 and Mac-1 in allergic airway responses in the rat, Am J Respir Crit Care Med, 149, 1186, 10.1164/ajrccm.149.5.8173758 Ramos-Barbon, 2001, Effect of alpha4-integrin blockade on CD4+ cell-driven late airway responses in the rat, Am J Respir Crit Care Med, 163, 101, 10.1164/ajrccm.163.1.2001093 Issekutz, 1991, T lymphocyte migration to arthritic joints and dermal inflammation in the rat: differing migration patterns and the involvement of VLA-4, Clin Immunol Immunopathol, 61, 436, 10.1016/S0090-1229(05)80014-5 Gosset, 1995, Expression of E-selectin, ICAM-1 and VCAM-1 on bronchial biopsies from allergic and non-allergic asthmatic patients, Int Arch Allergy Immunol, 106, 69, 10.1159/000236892 Pelaquini, 2010, Role of the Mac-1 and VLA-4 integrins, and concomitant Th2-cytokine production, in nitric oxide modulated eosinophil migration from bone marrow to lungs in allergic mice, Int Immunopharmacol Ravensberg, 2006, The effect of a single inhaled dose of a VLA-4 antagonist on allergen-induced airway responses and airway inflammation in patients with asthma, Allergy, 61, 1097, 10.1111/j.1398-9995.2006.01146.x Ihaku, 1999, Montelukast, a leukotriene receptor antagonist, inhibits the late airway response to antigen, airway eosinophilia, and IL-5- expressing cells in Brown Norway rats, J Allergy Clin Immunol, 104, 1147, 10.1016/S0091-6749(99)70006-0 Eum, 2003, Involvement of the cysteinyl-leukotrienes in allergen-induced airway eosinophilia and hyperresponsiveness in the mouse, Am J Respir Cell Mol Biol, 28, 25, 10.1165/rcmb.4532 Henderson, 1996, The importance of leukotrienes in airway inflammation in a mouse model of asthma, J Exp Med, 184, 1483, 10.1084/jem.184.4.1483 Wang, 1993, Role of leukotriene D4 in allergen-induced increases in airway smooth muscle in the rat, Am Rev Respir Dis, 148, 413, 10.1164/ajrccm/148.2.413 Salmon, 1999, Involvement of cysteinyl leukotrienes in airway smooth muscle cell DNA synthesis after repeated allergen exposure in sensitized Brown Norway rats, Br J Pharmacol, 127, 1151, 10.1038/sj.bjp.0702669 Henderson, 2006, Reversal of allergen-induced airway remodeling by CysLT1 receptor blockade, Am J Respir Crit Care Med, 173, 718, 10.1164/rccm.200501-088OC Vargaftig, 2003, Leukotrienes mediate part of ova-induced lung effects in mice via EGFR, Am J Physiology-Lung Cell Mol Physiol, 285, L808, 10.1152/ajplung.00377.2002 Kelly, 2006, Montelukast treatment attenuates the increase in myofibroblasts following low-dose allergen challenge, Chest, 130, 741, 10.1378/chest.130.3.741 Maekawa, 2009, GPR17 is a negative regulator of the cysteinyl leukotriene 1 receptor response to leukotriene D4, Proc Natl Acad Sci U S A, 106, 11685, 10.1073/pnas.0905364106 Maekawa, 2010, GPR17 regulates immune pulmonary inflammation induced by house dust mites, J Immunol, 185, 1846, 10.4049/jimmunol.1001131 Corry, 1996, Interleukin 4, but not interleukin 5 or eosinophils, is required in a murine model of acute airway hyperreactivity, J Exp Med, 183, 109, 10.1084/jem.183.1.109 Henderson, 2000, Soluble IL-4 receptor inhibits airway inflammation following allergen challenge in a mouse model of asthma, J Immunol, 164, 1086, 10.4049/jimmunol.164.2.1086 Borish, 2001, Efficacy of soluble IL-4 receptor for the treatment of adults with asthma, J Allergy Clin Immunol, 107, 963, 10.1067/mai.2001.115624 Lee, 2004, Defining a link with asthma in mice congenitally deficient in eosinophils, Science, 305, 1773, 10.1126/science.1099472 Kung, 1995, Involvement of IL-5 in a murine model of allergic pulmonary inflammation: prophylactic and therapeutic effect of an anti-IL-5 antibody, Am J Respir Cell Mol Biol, 13, 360, 10.1165/ajrcmb.13.3.7654390 Eum, 2005, IL-13 may mediate allergen-induced hyperresponsiveness independently of IL-5 or eotaxin by effects on airway smooth muscle, Am J Physiol Lung Cell Mol Physiol, 288, L576, 10.1152/ajplung.00380.2003 Mould, 2000, The effect of IL-5 and eotaxin expression in the lung on eosinophil trafficking and degranulation and the induction of bronchial hyperreactivity, J Immunol, 164, 2142, 10.4049/jimmunol.164.4.2142 Leckie, 2000, Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response, Lancet, 356, 2144, 10.1016/S0140-6736(00)03496-6 Nair, 2009, Mepolizumab for prednisone-dependent asthma with sputum eosinophilia, N Engl J Med, 360, 985, 10.1056/NEJMoa0805435 Haldar, 2009, Mepolizumab and exacerbations of refractory eosinophilic asthma, N Engl J Med, 360, 973, 10.1056/NEJMoa0808991 Allakhverdi, 2006, Multitargeted approach using antisense oligonucleotides for the treatment of asthma, Ann N Y Acad Sci, 1082, 62, 10.1196/annals.1348.047 Maes, 2011, Gene therapy for allergic airway diseases, Curr Allergy Asthma Rep, 11, 163, 10.1007/s11882-011-0177-8 Wills-Karp, 2001, IL-12/IL-13 axis in allergic asthma, J Allergy Clin Immunol, 107, 9, 10.1067/mai.2001.112265 Walter, 2001, Critical role for IL-13 in the development of allergen-induced airway hyperreactivity, J Immunol, 167, 4668, 10.4049/jimmunol.167.8.4668 Yang, 2004, Anti-IL-13 monoclonal antibody inhibits airway hyperresponsiveness, inflammation and airway remodeling, Cytokine, 28, 224, 10.1016/j.cyto.2004.08.007 Kuperman, 2002, Direct effects of interleukin-13 on epithelial cells cause airway hyperreactivity and mucus overproduction in asthma, Nat Med, 8, 885, 10.1038/nm734 Moore, 2002, IL-13 and IL-4 cause eotaxin release in human airway smooth muscle cells: a role for ERK, Am J Physiol Lung Cell Mol Physiol, 282, L847, 10.1152/ajplung.00245.2001 Doucet, 1998, IL-4 and IL-13 specifically increase adhesion molecule and inflammatory cytokine expression in human lung fibroblasts, Int Immunol, 10, 1421, 10.1093/intimm/10.10.1421 Whittaker, 2002, Interleukin-13 mediates a fundamental pathway for airway epithelial mucus induced by CD4 T cells and interleukin-9, Am J Respir Cell Mol Biol, 27, 593, 10.1165/rcmb.4838 Richter, 2001, The contribution of interleukin (IL)-4 and IL-13 to the epithelial-mesenchymal trophic unit in asthma, Am J Respir Cell Mol Biol, 25, 385, 10.1165/ajrcmb.25.3.4437 Zheng, 2008, IL-13 receptor alpha2 selectively inhibits IL-13-induced responses in the murine lung, J Immunol, 180, 522, 10.4049/jimmunol.180.1.522 Deshpande, 2004, Modulation of calcium signaling by interleukin-13 in human airway smooth muscle: role of CD38/cyclic adenosine diphosphate ribose pathway, Am J Respir Cell Mol Biol, 31, 36, 10.1165/rcmb.2003-0313OC Chiba, 2010, MicroRNAs and their therapeutic potential for human diseases: MiR-133a and bronchial smooth muscle hyperresponsiveness in asthma, J Pharmacol Sci, 114, 264, 10.1254/jphs.10R10FM Gauvreau, 2010, The effects of IL-13 blockade on allergen-induced airway responses in mild atopic asthma, Am J Respir Crit Care Med Tomkinson, 2010, Inhaled vs subcutaneous effects of a dual IL-4/IL-13 antagonist in a monkey model of asthma, Allergy, 65, 69, 10.1111/j.1398-9995.2009.02156.x Choi, 2005, TNF-alpha induces the late-phase airway hyperresponsiveness and airway inflammation through cytosolic phospholipase A(2) activation, J Allergy Clin Immunol, 116, 537, 10.1016/j.jaci.2005.05.034 Busse, 2009, Decrease in airway mucous gene expression caused by treatment with anti-tumor necrosis factor alpha in a murine model of allergic asthma, Ann Allergy Asthma Immunol, 103, 295, 10.1016/S1081-1206(10)60528-5 Berry, 2006, Evidence of a role of tumor necrosis factor alpha in refractory asthma, N Engl J Med, 354, 697, 10.1056/NEJMoa050580 Wenzel, 2009, A randomized, double-blind, placebo-controlled study of tumor necrosis factor-alpha blockade in severe persistent asthma, Am J Respir Crit Care Med, 179, 549, 10.1164/rccm.200809-1512OC Temann, 1998, Expression of interleukin 9 in the lungs of transgenic mice causes airway inflammation, mast cell hyperplasia, and bronchial hyperresponsiveness, J Exp Med, 188, 1307, 10.1084/jem.188.7.1307 Temann, 2007, IL9 leads to airway inflammation by inducing IL13 expression in airway epithelial cells, Int Immunol, 19, 1, 10.1093/intimm/dxl117 Cheng, 2002, Anti-interleukin-9 antibody treatment inhibits airway inflammation and hyperreactivity in mouse asthma model, Am J Respir Crit Care Med, 166, 409, 10.1164/rccm.2105079 McMillan, 2002, The absence of interleukin 9 does not affect the development of allergen-induced pulmonary inflammation nor airway hyperreactivity, J Exp Med, 195, 51, 10.1084/jem.20011732 Kearley, 2010, IL-9 governs allergen-induced mast cell numbers in the lung and chronic remodeling of the airways, Am J Respir Crit Care Med Shimbara, 2000, IL-9 and its receptor in allergic and nonallergic lung disease: increased expression in asthma, J Allergy Clin Immunol, 105, 108, 10.1016/S0091-6749(00)90185-4 White, 2009, Two first-in-human, open-label, phase I dose-escalation safety trials of MEDI-528, a monoclonal antibody against interleukin-9, in healthy adult volunteers, Clin Ther, 31, 728, 10.1016/j.clinthera.2009.04.019 Blease, 2000, Airway remodeling is absent in CCR1-/- mice during chronic fungal allergic airway disease, J Immunol, 165, 1564, 10.4049/jimmunol.165.3.1564 Schuh, 2002, The role of CC chemokine receptor 5 (CCR5) and RANTES/CCL5 during chronic fungal asthma in mice, FASEB J, 16, 228, 10.1096/fj.01-0528fje Schuh, 2002, Eotaxin/CCL11 is involved in acute, but not chronic, allergic airway responses to Aspergillus fumigatus, Am J Physiol Lung Cell Mol Physiol, 283, L198, 10.1152/ajplung.00341.2001 Vijayanand, 2010, Chemokine receptor 4 plays a key role in T cell recruitment into the airways of asthmatic patients, J Immunol, 184, 4568, 10.4049/jimmunol.0901342 Perros, 2009, Blockade of CCR4 in a humanized model of asthma reveals a critical role for DC-derived CCL17 and CCL22 in attracting Th2 cells and inducing airway inflammation, Allergy, 64, 995, 10.1111/j.1398-9995.2009.02095.x Finotto, 2002, Development of spontaneous airway changes consistent with human asthma in mice lacking T-bet, Science, 295, 336, 10.1126/science.1065544 Gavett, 1995, Interleukin 12 inhibits antigen-induced airway hyperresponsiveness, inflammation, and Th2 cytokine expression in mice, J Exp Med, 182, 1527, 10.1084/jem.182.5.1527 Schwarze, 1998, Local treatment with IL-12 is an effective inhibitor of airway hyperresponsiveness and lung eosinophilia after airway challenge in sensitized mice, J Allergy Clin Immunol, 102, 86, 10.1016/S0091-6749(98)70058-2 Okano, 1998, Interleukin-12 inhibits production of interleukin-5 but not of granulocyte/macrophage colony-stimulating factor by antigen-stimulated blood mononuclear cells in allergic bronchial asthmatics, Int Arch Allergy Immunol, 115, 83, 10.1159/000023834 Boguniewicz, 1993, Treatment of steroid-dependent asthma with recombinant interferon-gamma, Clin Exp Allergy, 23, 785, 10.1111/j.1365-2222.1993.tb00367.x Bryan, 2000, Effects of recombinant human interleukin-12 on eosinophils, airway hyper-responsiveness, and the late asthmatic response, Lancet, 356, 2149, 10.1016/S0140-6736(00)03497-8 Kline, 1998, Modulation of airway inflammation by CpG oligodeoxynucleotides in a murine model of asthma, J Immunol, 160, 2555, 10.4049/jimmunol.160.6.2555 Hessel, 2005, Immunostimulatory oligonucleotides block allergic airway inflammation by inhibiting Th2 cell activation and IgE-mediated cytokine induction, J Exp Med, 202, 1563, 10.1084/jem.20050631 Tulic, 2004, Amb a 1-immunostimulatory oligodeoxynucleotide conjugate immunotherapy decreases the nasal inflammatory response, J Allergy Clin Immunol, 113, 235, 10.1016/j.jaci.2003.11.001 Gauvreau, 2006, Immunostimulatory sequences regulate interferon-inducible genes but not allergic airway responses, Am J Respir Crit Care Med, 174, 15, 10.1164/rccm.200601-057OC Moisan, 2006, TLR7 ligand prevents allergen-induced airway hyperresponsiveness and eosinophilia in allergic asthma by a MYD88-dependent and MK2-independent pathway, Am J Physiology-Lung Cell Mol Physiol, 290, L987, 10.1152/ajplung.00440.2005 Camateros, 2007, Chronic asthma-induced airway remodeling is prevented by toll-like receptor-7/8 ligand S28463, Am J Respir Crit Care Med, 175, 1241, 10.1164/rccm.200701-054OC Blease, 2001, IL-13 fusion cytotoxin ameliorates chronic fungal-induced allergic airway disease in mice, J Immunol, 167, 6583, 10.4049/jimmunol.167.11.6583 Thorburn, 2010, Pneumococcal conjugate vaccine-induced regulatory T cells suppress the development of allergic airways disease, Thorax, 65, 1053, 10.1136/thx.2009.131508 Preston, 2011, Streptococcus pneumoniae infection suppresses allergic airways disease by inducing regulatory T-cells, Eur Respir J, 37, 53, 10.1183/09031936.00049510 Blease, 2005, Targeting kinases in asthma, Expert Opin Investig Drugs, 14, 1213, 10.1517/13543784.14.10.1213 Duan, 2004, Anti-inflammatory effects of mitogen-activated protein kinase kinase inhibitor U0126 in an asthma mouse model, J Immunol, 172, 7053, 10.4049/jimmunol.172.11.7053 Underwood, 2000, SB 239063, a potent p38 MAP kinase inhibitor, reduces inflammatory cytokine production, airways eosinophil infiltration, and persistence, J Pharmacol Exp Ther, 293, 281 Nath, 2005, Potential role of c-Jun NH2-terminal kinase in allergic airway inflammation and remodelling: effects of SP600125, Eur J Pharmacol, 506, 273, 10.1016/j.ejphar.2004.11.040 Eynott, 2003, Allergen-induced inflammation and airway epithelial and smooth muscle cell proliferation: role of Jun N-terminal kinase, Br J Pharmacol, 140, 1373, 10.1038/sj.bjp.0705569 Stenton, 2002, Inhibition of allergic inflammation in the airways using aerosolized antisense to Syk kinase, J Immunol, 169, 1028, 10.4049/jimmunol.169.2.1028 Matsubara, 2006, Inhibition of spleen tyrosine kinase prevents mast cell activation and airway hyperresponsiveness, Am J Respir Crit Care Med, 173, 56, 10.1164/rccm.200503-361OC Polosa, 2002, Expression of c-erbB receptors and ligands in the bronchial epithelium of asthmatic subjects, J Allergy Clin Immunol, 109, 75, 10.1067/mai.2002.120274 Takeyama, 2008, Role of epidermal growth factor receptor in maintaining airway goblet cell hyperplasia in rats sensitized to allergen, Clin Exp Allergy, 38, 857, 10.1111/j.1365-2222.2008.02951.x Hirota, 2011, In vivo role of platelet derived growth Factor-BB in airway smooth muscle proliferation in mouse lung, Am J Respir Cell Mol Biol, 10.1165/rcmb.2010-0277OC Lee, 2004, Vascular endothelial growth factor (VEGF) induces remodeling and enhances TH2-mediated sensitization and inflammation in the lung, Nat Med, 10, 1095, 10.1038/nm1105 Ammit, 2001, Sphingosine 1-phosphate modulates human airway smooth muscle cell functions that promote inflammation and airway remodeling in asthma, Faseb J, 15, 1212, 10.1096/fj.00-0742fje Nishiuma, 2008, Inhalation of sphingosine kinase inhibitor attenuates airway inflammation in asthmatic mouse model, Am J Physiol Lung Cell Mol Physiol, 294, L1085, 10.1152/ajplung.00445.2007 Matloubian, 2004, Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1, Nature, 427, 355, 10.1038/nature02284 White, 2010, Chlorine gas inhalation: human clinical evidence of toxicity and experience in animal models, Proc Am Thorac Soc, 7, 257, 10.1513/pats.201001-008SM Leustik, 2008, Mitigation of chlorine-induced lung injury by low-molecular-weight antioxidants, Am J Physiol Lung Cell Mol Physiol, 295, L733, 10.1152/ajplung.90240.2008 Nadeem, 2003, Increased oxidative stress and altered levels of antioxidants in asthma, J Allergy Clin Immunol, 111, 72, 10.1067/mai.2003.17 Trifilieff, 2009, Role of sphingosine-1-phosphate (S1P) and the S1P(2) receptor in allergen-induced, mast cell-dependent contraction of rat lung parenchymal strips, Naunyn Schmiedebergs Arch Pharmacol, 380, 303, 10.1007/s00210-009-0438-4 Imaoka, 2007, Effects of thioredoxin on established airway remodeling in a chronic antigen exposure asthma model, Biochem Biophys Res Commun, 360, 525, 10.1016/j.bbrc.2007.06.019 Caceres, 2009, A sensory neuronal ion channel essential for airway inflammation and hyperreactivity in asthma, Proc Natl Acad Sci U S A, 106, 9099, 10.1073/pnas.0900591106 Maghni, 2000, Dichotomy between neurokinin receptor actions in modulating allergic airway responses in an animal model of helper T cell type 2 cytokine- associated inflammation, Am J Respir Crit Care Med, 162, 1068, 10.1164/ajrccm.162.3.9910089 Anderson, 2008, Endotyping asthma: new insights into key pathogenic mechanisms in a complex, heterogeneous disease, Lancet, 372, 1107, 10.1016/S0140-6736(08)61452-X Bautista, 2006, TRPA1 mediates the inflammatory actions of environmental irritants and proalgesic agents, Cell, 124, 1269, 10.1016/j.cell.2006.02.023 Bianchi, 2007, DAMPs, PAMPs and alarmins: all we need to know about danger, J Leukoc Biol, 81, 1, 10.1189/jlb.0306164